222 related articles for article (PubMed ID: 30535292)
21. Two Cases of Successful Ustekinumab Treatment for Non-infectious Uveitis Associated With Crohn's Disease.
Chateau T; Angioi K; Peyrin-Biroulet L
J Crohns Colitis; 2020 May; 14(4):571. PubMed ID: 31606743
[No Abstract] [Full Text] [Related]
22. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.
Tan MH; Gordon M; Lebwohl O; George J; Lebwohl MG
Arch Dermatol; 2001 Jul; 137(7):930-3. PubMed ID: 11453813
[TBL] [Abstract][Full Text] [Related]
23. Ustekinumab as Effective Treatment for Refractory Amicrobial Pustulosis of the Folds Associated with Crohn's Disease.
Al-Raddadi R; Frances C; Moguelet P; Bachmeyer C; Guégan S
Acta Derm Venereol; 2017 Mar; 97(3):389-390. PubMed ID: 27722763
[No Abstract] [Full Text] [Related]
24. Pyoderma gangrenosum and tumor necrosis factor α agents.
Rallis E; Koumantaki-Mathioudaki E; Tsiatoura A; Stavropoulos P; Katsambas A
Cutis; 2013 Oct; 92(4):E1-2. PubMed ID: 24195097
[No Abstract] [Full Text] [Related]
25. Successful Treatment With Ustekinumab for Enterocutaneous Fistulas in Crohn's Disease.
Madarame A; Kimura H; Kunisaki R
J Crohns Colitis; 2020 May; 14(4):569-570. PubMed ID: 31616911
[No Abstract] [Full Text] [Related]
26. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
27. Scrotal pyoderma gangrenosum associated with Crohn's disease.
Ho SA; Tan WP; Tan AW; Wong SN; Chua SH
Singapore Med J; 2009 Dec; 50(12):e397-400. PubMed ID: 20087538
[TBL] [Abstract][Full Text] [Related]
28. Infliximab for peristomal pyoderma gangrenosum.
Mimouni D; Anhalt GJ; Kouba DJ; Nousari HC
Br J Dermatol; 2003 Apr; 148(4):813-6. PubMed ID: 12752145
[TBL] [Abstract][Full Text] [Related]
29. Efficiency of Ustekinumab in Crohn's Disease with Severe Psoriasiform Rash Induced by Biotherapies in an Adolescent.
Bertrand V; El Haite A; Carré D
Pediatr Dermatol; 2017 Jul; 34(4):e214-e215. PubMed ID: 28436109
[TBL] [Abstract][Full Text] [Related]
30. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.
López San Román A; Bermejo F; Aldanondo I; Carrera E; Boixeda D; Muñoz Zato E
Rev Esp Enferm Dig; 2004 Jun; 96(6):420-2; 422-4. PubMed ID: 15230672
[TBL] [Abstract][Full Text] [Related]
31. High-dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum.
Greb JE; Gottlieb AB; Goldminz AM
Dermatol Ther; 2016 Nov; 29(6):482-483. PubMed ID: 27502191
[No Abstract] [Full Text] [Related]
32. Treatment of pyoderma gangrenosum with infliximab in Crohn's disease.
Sapienza MS; Cohen S; Dimarino AJ
Dig Dis Sci; 2004 Sep; 49(9):1454-7. PubMed ID: 15481318
[TBL] [Abstract][Full Text] [Related]
33. The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies.
Narula N; Aruljothy A; Wong ECL; Homenauth R; Alshahrani AA; Marshall JK; Reinisch W
United European Gastroenterol J; 2021 Jun; 9(5):581-589. PubMed ID: 34077627
[TBL] [Abstract][Full Text] [Related]
34. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
Carp JM; Onuma E; Das K; Gottlieb AB
Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
[TBL] [Abstract][Full Text] [Related]
35. Metastatic Cutaneous Crohn's Disease of the Face-A Case Successfully Treated With Ustekinumab.
Martins Figueiredo L; Oliveira AM; Martins A
J Crohns Colitis; 2020 Jul; 14(6):874-875. PubMed ID: 31630151
[No Abstract] [Full Text] [Related]
36. Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy.
Ganzleben I; Hirschmann S; Köhler J; Fuchs FS; Rieker RJ; Baer E; Klenske E; Nagore D; Neurath MF; Atreya R
Am J Gastroenterol; 2020 Apr; 115(4):632-634. PubMed ID: 32149778
[No Abstract] [Full Text] [Related]
37. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
38. [Ustekinumab for the treatment of Crohn's disease -Indication of Ustekinumab according to efficacy and safety].
Ishihara S; Kawashima K; Kinoshita Y
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(3):216-223. PubMed ID: 30853674
[No Abstract] [Full Text] [Related]
39. Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin.
Razmi T M; Muhammed H; Handa S; Malhotra P; Sharma S; Saikia UN; Aggarwal R; Dogra S
Clin Exp Dermatol; 2019 Mar; 44(2):e13-e15. PubMed ID: 30294832
[No Abstract] [Full Text] [Related]
40. [Pyoderma gangrenosum associated with Crohn's disease].
Mikić D; Bojić I; Zecević R; Marinković V; Lukacević S
Vojnosanit Pregl; 1995; 52(5):505-8. PubMed ID: 8545995
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]